BAP1 and neoplasm: Description of demographic and tumor variables with pairwise comparisons for 142 divided into two cohorts depending on whether tumors were selected from archived samples for which both tumor and blood samples were available (cohort 1, N=90) or tumors for which BAP1 sequencing was specifically requested (cohort 2, N=52).